{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:04:18Z","timestamp":1791126258593,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T00:00:00Z","timestamp":1139961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00213-005-0281-3","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T08:22:45Z","timestamp":1139905365000},"page":"208-217","source":"Crossref","is-referenced-by-count":57,"title":["Pharmacological characterisation of place escape\/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain"],"prefix":"10.1007","volume":"185","author":[{"given":"Louise H.","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Blackburn-Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,2,15]]},"reference":[{"key":"281_CR1","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280:1831\u20131836","journal-title":"JAMA"},{"key":"281_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(01)01029-9","volume":"421","author":"L Bardin","year":"2001","unstructured":"Bardin L, Tarayre JP, Koek W, Colpaert FC (2001) In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. Eur J Pharmacol 421:109\u2013114","journal-title":"Eur J Pharmacol"},{"key":"281_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","volume":"33","author":"GJ Bennett","year":"1988","unstructured":"Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87\u2013107","journal-title":"Pain"},{"key":"281_CR4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tips.2004.04.008","volume":"25","author":"G Blackburn-Munro","year":"2004","unstructured":"Blackburn-Munro G (2004) Pain-like behaviours in animals\u2014how human are they? Trends Pharmacol Sci 25:299\u2013305","journal-title":"Trends Pharmacol Sci"},{"key":"281_CR5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.0007-1331.2001.00727.x","volume":"13","author":"G Blackburn-Munro","year":"2001","unstructured":"Blackburn-Munro G, Blackburn-Munro RE (2001) Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 13:1009\u20131023","journal-title":"J Neuroendocrinol"},{"key":"281_CR6","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2174\/1381612054865000","volume":"11","author":"G Blackburn-Munro","year":"2005","unstructured":"Blackburn-Munro G, Erichsen HK (2005) Antiepileptics and the treatment of neuropathic pain: evidence from animal models. Curr Pharm Des 11:2961\u20132976","journal-title":"Curr Pharm Des"},{"key":"281_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2004.04.007","volume":"47","author":"G Blackburn-Munro","year":"2004","unstructured":"Blackburn-Munro G, Bomholt SF, Erichsen HK (2004) Behavioural effects of the novel AMPA\/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain. Neuropharmacology 47:351\u2013362","journal-title":"Neuropharmacology"},{"key":"281_CR8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","volume":"48","author":"SF Bomholt","year":"2005","unstructured":"Bomholt SF, Mikkelsen JD, Blackburn-Munro G (2005) Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48:252\u2013263","journal-title":"Neuropharmacology"},{"key":"281_CR9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0704110","volume":"133","author":"D Bridges","year":"2001","unstructured":"Bridges D, Ahmad K, Rice AS (2001) The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br J Pharmacol 133:586\u2013594","journal-title":"Br J Pharmacol"},{"key":"281_CR10","first-page":"264","volume-title":"The neuropharmacological basis of reward","author":"GD Carr","year":"1989","unstructured":"Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebmann JM, Cooper SJ (eds) The neuropharmacological basis of reward. Clarendon, Oxford, pp 264\u2013319"},{"key":"281_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3959(01)00305-0","volume":"93","author":"D Christensen","year":"2001","unstructured":"Christensen D, Gautron M, Guilbaud G, Kayser V (2001) Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain 93:147\u2013153","journal-title":"Pain"},{"key":"281_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3959(87)90117-5","volume":"28","author":"FC Colpaert","year":"1987","unstructured":"Colpaert FC (1987) Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain 28:201\u2013222","journal-title":"Pain"},{"key":"281_CR13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0028-3908(02)00119-3","volume":"43","author":"FC Colpaert","year":"2002","unstructured":"Colpaert FC, Tarayre JP, Koek W, Pauwels PJ, Bardin L, Xu XJ, Wiesenfeld-Hallin Z, Cosi C, Carilla-Durand E, Assie MB, Vacher B (2002) Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology 43:945\u2013958","journal-title":"Neuropharmacology"},{"key":"281_CR14","first-page":"183","volume-title":"Textbook of pain","author":"AD Craig","year":"1999","unstructured":"Craig AD, Dostrovsky JO (1999) Medulla to thalamus. In: Wall PD, Melzack R (eds) Textbook of pain. Churchill Livingstone, UK, pp 183\u2013214"},{"key":"281_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","volume":"87","author":"I Decosterd","year":"2000","unstructured":"Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149\u2013158","journal-title":"Pain"},{"key":"281_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.euroneuro.2004.01.004","volume":"14","author":"J Vry De","year":"2004","unstructured":"De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR (2004) 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 14:487\u2013495","journal-title":"Eur Neuropsychopharmacol"},{"key":"281_CR17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0278-5846(96)00005-X","volume":"20","author":"KR Dimond","year":"1996","unstructured":"Dimond KR, Pande AC, Lamoreaux L, Pierce MW (1996) Effect of gabapentin (Neurontin) on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 20:407\u2013417","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"281_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pain.2005.03.037","volume":"116","author":"A Dyson","year":"2005","unstructured":"Dyson A, Peacock M, Chen A, Courade JP, Yaqoob M, Groarke A, Brain C, Loong Y, Fox A (2005) Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat. Pain 116:129\u2013137","journal-title":"Pain"},{"key":"281_CR19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pain.2005.05.004","volume":"116","author":"HK Erichsen","year":"2005","unstructured":"Erichsen HK, Hao JX, Xu XJ, Blackburn-Munro G (2005) Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain. Pain 116:347\u2013358","journal-title":"Pain"},{"key":"281_CR20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1124\/jpet.102.033134","volume":"303","author":"MJ Field","year":"2002","unstructured":"Field MJ, Gonzalez MI, Tallarida RJ, Singh L (2002) Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain. J Pharmacol Exp Ther 303:730\u2013735","journal-title":"J Pharmacol Exp Ther"},{"key":"281_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","volume":"92","author":"A Fox","year":"2001","unstructured":"Fox A, Kesingland A, Gentry C, McNair K, Patel S, Urban L, James I (2001) The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92:91\u2013100","journal-title":"Pain"},{"key":"281_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1568026023393525","volume":"2","author":"B Frolund","year":"2002","unstructured":"Frolund B, Ebert B, Kristiansen U, Liljefors T, Krogsgaard-Larsen P (2002) GABA(A) receptor ligands and their therapeutic potentials. Curr Top Med Chem 2:817\u2013832","journal-title":"Curr Top Med Chem"},{"key":"281_CR23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","volume":"60","author":"JS Gimbel","year":"2003","unstructured":"Gimbel JS, Richards P, Portenoy RK (2003) Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 60:927\u2013934","journal-title":"Neurology"},{"key":"281_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109\u2013118","journal-title":"Pain"},{"key":"281_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(99)00402-1","volume":"377","author":"G Griffin","year":"1999","unstructured":"Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME (1999) Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol 377:117\u2013125","journal-title":"Eur J Pharmacol"},{"key":"281_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pain.2004.11.023","volume":"113","author":"SE Harte","year":"2005","unstructured":"Harte SE, Kender RG, Borszcz GS (2005) Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation. Pain 113:405\u2013415","journal-title":"Pain"},{"key":"281_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/35053509","volume":"2","author":"SP Hunt","year":"2001","unstructured":"Hunt SP, Mantyh PW (2001) The molecular dynamics of pain control. Nat Rev Neurosci 2:83\u201391","journal-title":"Nat Rev Neurosci"},{"key":"281_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(97)00070-8","volume":"324","author":"JC Hunter","year":"1997","unstructured":"Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ (1997) The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324:153\u2013160","journal-title":"Eur J Pharmacol"},{"key":"281_CR29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/jpet.104.070656","volume":"311","author":"S Iyengar","year":"2004","unstructured":"Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RM (2004) Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther 311:576\u2013584","journal-title":"J Pharmacol Exp Ther"},{"key":"281_CR30","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1073\/pnas.141218998","volume":"98","author":"JP Johansen","year":"2001","unstructured":"Johansen JP, Fields HL, Manning BH (2001) The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A 98:8077\u20138082","journal-title":"Proc Natl Acad Sci U S A"},{"key":"281_CR31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","volume":"50","author":"SH Kim","year":"1992","unstructured":"Kim SH, Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355\u2013363","journal-title":"Pain"},{"key":"281_CR32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1006\/exnr.2000.7395","volume":"163","author":"CJ LaBuda","year":"2000","unstructured":"LaBuda CJ, Fuchs PN (2000a) A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Exp Neurol 163:490\u2013494","journal-title":"Exp Neurol"},{"key":"281_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(00)01340-9","volume":"290","author":"CJ LaBuda","year":"2000","unstructured":"LaBuda CJ, Fuchs PN (2000b) Morphine and gabapentin decrease mechanical hyperalgesia and escape\/avoidance behavior in a rat model of neuropathic pain. Neurosci Lett 290:137\u2013140","journal-title":"Neurosci Lett"},{"key":"281_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(01)01787-6","volume":"304","author":"CJ LaBuda","year":"2001","unstructured":"LaBuda CJ, Fuchs PN (2001) Low dose aspirin attenuates escape\/avoidance behavior, but does not reduce mechanical hyperalgesia in a rodent model of inflammatory pain. Neurosci Lett 304:137\u2013140","journal-title":"Neurosci Lett"},{"key":"281_CR35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jneumeth.2004.11.008","volume":"144","author":"CJ LaBuda","year":"2005","unstructured":"LaBuda CJ, Little PJ (2005) Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 144:175\u2013181","journal-title":"J Neurosci Methods"},{"key":"281_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.expneurol.2004.04.003","volume":"188","author":"SC LaGraize","year":"2004","unstructured":"LaGraize SC, Labuda CJ, Rutledge MA, Jackson RL, Fuchs PN (2004) Differential effect of anterior cingulate cortex lesion on mechanical hypersensitivity and escape\/avoidance behavior in an animal model of neuropathic pain. Exp Neurol 188:139\u2013148","journal-title":"Exp Neurol"},{"key":"281_CR36","doi-asserted-by":"crossref","unstructured":"LaGraize SC, Borzan J, Peng YB, Fuchs PN (2005) Selective regulation of pain affect following activation of the opioid anterior cingulate cortex system. Exp Neurol (in press)","DOI":"10.1016\/j.expneurol.2005.05.008"},{"key":"281_CR38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","volume":"53","author":"D Bars Le","year":"2001","unstructured":"Le Bars D, Gozariu M, Cadden SW (2001) Animal models of nociception. Pharmacol Rev 53:597\u2013652","journal-title":"Pharmacol Rev"},{"key":"281_CR39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1124\/jpet.102.041574","volume":"303","author":"ZD Luo","year":"2002","unstructured":"Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, Myers RR (2002) Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303:1199\u20131205","journal-title":"J Pharmacol Exp Ther"},{"key":"281_CR40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0009-3084(02)00155-X","volume":"121","author":"TP Malan Jr","year":"2002","unstructured":"Malan TP Jr, Ibrahim MM, Vanderah TW, Makriyannis A, Porreca F (2002) Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Chem Phys Lipids 121:191\u2013200","journal-title":"Chem Phys Lipids"},{"key":"281_CR41","first-page":"423","volume-title":"The skin sneses","author":"R Melzack","year":"1968","unstructured":"Melzack R, Casey KL (1968) Sensory, motivational, and central control determinants of pain. In: Kenshalo DR (ed) The skin sneses. CC Thomas, Springfield, pp 423\u2013439"},{"key":"281_CR42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2005.03.019","volume":"382","author":"VA Mitchell","year":"2005","unstructured":"Mitchell VA, Aslan S, Safaei R, Vaughan CW (2005) Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain. Neurosci Lett 382:231\u2013235","journal-title":"Neurosci Lett"},{"key":"281_CR43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pain.2004.09.028","volume":"112","author":"JS Mogil","year":"2004","unstructured":"Mogil JS, Crager SE (2004) What should we be measuring in behavioral studies of chronic pain in animals? Pain 112:12\u201315","journal-title":"Pain"},{"key":"281_CR44","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","volume":"159","author":"CM Morello","year":"1999","unstructured":"Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999) Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159:1931\u20131937","journal-title":"Arch Intern Med"},{"key":"281_CR45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.2005.00523.x","volume":"426","author":"DJ Muzina","year":"2005","unstructured":"Muzina DJ, Elhaj O, Gajwani P, Gao K, Calabrese JR (2005) Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr Scand Suppl 426:21\u201328","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"281_CR46","unstructured":"Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T (2005) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology (in press). DOI 10.1038\/sj.npp.13300858 locator-type=\"URL\">DOI 10.1038\/sj.npp.13300858"},{"key":"281_CR47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00018-004-4283-9","volume":"62","author":"PT Ohara","year":"2005","unstructured":"Ohara PT, Vit JP, Jasmin L (2005) Cortical modulation of pain. Cell Mol Life Sci 62:44\u201352","journal-title":"Cell Mol Life Sci"},{"key":"281_CR48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(00)00404-8","volume":"90","author":"S Patel","year":"2001","unstructured":"Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, Fox A (2001) The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90:217\u2013226","journal-title":"Pain"},{"key":"281_CR49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-005-0120-6","volume":"182","author":"LH Pedersen","year":"2005","unstructured":"Pedersen LH, Nielsen AN, Blackburn-Munro G (2005) Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology (Berl) 182:551\u2013561","journal-title":"Psychopharmacology (Berl)"},{"key":"281_CR50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<391::AID-JNR12>3.0.CO;2-A","volume":"51","author":"DA Pettit","year":"1998","unstructured":"Pettit DA, Harrison MP, Olson JM, Spencer RF, Cabral GA (1998) Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res 51:391\u2013402","journal-title":"J Neurosci Res"},{"key":"281_CR51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0304-3959(77)90063-X","volume":"3","author":"DD Price","year":"1977","unstructured":"Price DD, Dubner R (1977) Neurons that subserve the sensory-discriminative aspects of pain. Pain 3:307\u2013338","journal-title":"Pain"},{"key":"281_CR52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3959(88)90001-2","volume":"8","author":"DD Price","year":"1980","unstructured":"Price DD, Barrell JJ, Gracely RH (1980) A psychophysical analysis of experimental factors that selectively influence the affective dimension of pain. Pain 8:137\u2013149","journal-title":"Pain"},{"key":"281_CR53","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","volume":"59","author":"SN Raja","year":"2002","unstructured":"Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB (2002) Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 59:1015\u20131021","journal-title":"Neurology"},{"key":"281_CR54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2005.04.034","volume":"516","author":"F Rode","year":"2005","unstructured":"Rode F, Jensen DG, Blackburn-Munro G, Bjerrum OJ (2005) Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur J Pharmacol 516:131\u2013138","journal-title":"Eur J Pharmacol"},{"key":"281_CR55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0168-0102(90)90008-3","volume":"7","author":"ED Schomburg","year":"1990","unstructured":"Schomburg ED (1990) Spinal sensorimotor systems and their supraspinal control. Neurosci Res 7:265\u2013340","journal-title":"Neurosci Res"},{"key":"281_CR56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","volume":"43","author":"Z Seltzer","year":"1990","unstructured":"Seltzer Z, Dubner R, Shir Y (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43:205\u2013218","journal-title":"Pain"},{"key":"281_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","volume":"105","author":"CP Watson","year":"2003","unstructured":"Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J (2003) Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105:71\u201378","journal-title":"Pain"},{"key":"281_CR58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0304-3959(84)90045-9","volume":"18","author":"CJ Woolf","year":"1984","unstructured":"Woolf CJ (1984) Long term alterations in the excitability of the flexion reflex produced by peripheral tissue injury in the chronic decerebrate rat. Pain 18:325\u2013343","journal-title":"Pain"},{"key":"281_CR59","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0006-3223(97)00305-3","volume":"42","author":"LT Young","year":"1997","unstructured":"Young LT, Robb JC, Patelis-Siotis I, MacDonald C, Joffe RT (1997) Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 42:851\u2013853","journal-title":"Biol Psychiatry"},{"key":"281_CR60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109\u2013110","journal-title":"Pain"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0281-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-0281-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0281-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:43:29Z","timestamp":1736275409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-0281-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,15]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-0281-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,15]]}}}